drugset / Trial / NCT06053242

Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain

NCT06053242 ↗

Phase 1/2 Recruiting 45 enrolled Creative Medical Technology Holdings Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The brief purpose of this research study is to learn about the safety, tolerability, and efficacy of paraspinal intramuscular injection of CELZ-201-DDT in patients with chronic lower back pain.

Timeline

Start
2024-05-21
Primary completion
2026-05-01
Completion
2027-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CELZ-201-DDT Cell therapy 6 cells Intramuscular
Subject CELZ-201-DDT Cell therapy 30 cells Intramuscular
Subject CELZ-201-DDT Cell therapy 60 cells Intramuscular
Subject CELZ-201-DDT Cell therapy 120 cells Intramuscular